mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism
-
Published:2024-05-14
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Levy Tal, Voeltzke Kai, Hruby Laura, Alasad KhawlaORCID, Bas Zuelal, Snaebjörnsson MarteinnORCID, Marciano Ran, Scharov Katerina, Planque MélanieORCID, Vriens Kim, Christen Stefan, Funk Cornelius M.ORCID, Hassiepen Christina, Kahler AlisaORCID, Heider Beate, Picard DanielORCID, Lim Jonathan K. M.ORCID, Stefanski Anja, Bendrin Katja, Vargas-Toscano AndresORCID, Kahlert Ulf D.ORCID, Stühler Kai, Remke MarcORCID, Elkabets Moshe, Grünewald Thomas G. P.ORCID, Reichert Andreas S.ORCID, Fendt Sarah-MariaORCID, Schulze AlmutORCID, Reifenberger Guido, Rotblat BarakORCID, Leprivier GabrielORCID
Abstract
AbstractEnergetic stress compels cells to evolve adaptive mechanisms to adjust their metabolism. Inhibition of mTOR kinase complex 1 (mTORC1) is essential for cell survival during glucose starvation. How mTORC1 controls cell viability during glucose starvation is not well understood. Here we show that the mTORC1 effectors eukaryotic initiation factor 4E binding proteins 1/2 (4EBP1/2) confer protection to mammalian cells and budding yeast under glucose starvation. Mechanistically, 4EBP1/2 promote NADPH homeostasis by preventing NADPH-consuming fatty acid synthesis via translational repression of Acetyl-CoA Carboxylase 1 (ACC1), thereby mitigating oxidative stress. This has important relevance for cancer, as oncogene-transformed cells and glioma cells exploit the 4EBP1/2 regulation of ACC1 expression and redox balance to combat energetic stress, thereby supporting transformation and tumorigenicity in vitro and in vivo. Clinically, high EIF4EBP1 expression is associated with poor outcomes in several cancer types. Our data reveal that the mTORC1-4EBP1/2 axis provokes a metabolic switch essential for survival during glucose starvation which is exploited by transformed and tumor cells.
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Gullino, P. M., Clark, S. H. & Grantham, F. H. The Interstitial Fluid of Solid Tumors. Cancer Res. 24, 780–794 (1964). 2. Nagy, J. A., Chang, S. H., Dvorak, A. M. & Dvorak, H. F. Why are tumour blood vessels abnormal and why is it important to know? Br. J. Cancer 100, 865–869 (2009). 3. Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8, e44235 (2019). 4. Caro-Maldonado, A. Dying for Something to Eat: How Cells Respond to Starvation. Open Cell Signaling J. 3, 42–51 (2011). 5. Lin, S. C. & Hardie, D. G. AMPK: Sensing Glucose as well as Cellular Energy Status. Cell Metab. 27, 299–313 (2018).
|
|